Oral News and Research

RSS

New discovery could lead to more effective treatments for asthma sufferers

New research led by Edith Cowan University has made an important discovery that could lead to more effective treatments for the world's 262 million asthma sufferers.

4 Jul 2022

Researchers investigate prevention and therapy against monkeypox infection

Researchers reviewed the preventive and therapeutic measures against monkeypox.

4 Jul 2022

Study highlights the non-inferiority of frozen sperm for intrauterine insemination treatments

Patients having intrauterine insemination for fertility treatment can be reassured that the use of cryopreserved sperm instead of fresh is not associated with inferior outcomes.

4 Jul 2022

SARS-CoV-2 can evade Paxlovid by multiple mechanisms

In a recent article posted to the bioRxiv* preprint server, researchers at Rutgers, the State University of New Jersey, the University of South Florida, and the Catholic University of America demonstrated that the natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) mutations result in nirmatrelvir resistance.

30 Jun 2022

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

Antibiotic-resistant strains of Salmonella Typhi, the typhoid bacteria, have spread from South Asia to other countries nearly 200 times since 1990, new research suggests.

29 Jun 2022

What you need to know about monkeypox

The World Health Organization said June 25 that monkeypox wasn't yet a public health emergency of international concern. More than 4,500 cases have been reported worldwide, with more than 300 in the U.S. And with public health officials unable to follow all chains of transmission, they're likely undercounting cases.

29 Jun 2022

Drug-resistant typhoid needs to be treated as a global problem

The bacteria that causes typhoid fever is becoming increasingly resistant to common antibiotics used to treat the disease, with resistant strains spreading to hundreds of countries in the past three decades, new analysis shows.

29 Jun 2022

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

A recent study posted to the bioRxiv* preprint server assessed whether niclosamide could be employed in coronavirus disease 2019 (COVID-19) therapy.

28 Jun 2022

Researchers examine the role of perineural invasion in oral cancer outcomes

One of the most terrifying aspects of cancer is its unpredictability: Some cancerous tumors are cured by treatment, while others shrink with treatment only to return later.

27 Jun 2022

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.

27 Jun 2022

Does fecal viral excretion provide insights into on GI symptoms of COVID-19?

Researchers discuss the physiopathological mechanisms associated with digestive symptoms associated with COVID-19.

27 Jun 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

AbbVie today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

27 Jun 2022

Study examines the cost-effectiveness of AI-supported detection of proximal caries

The Interactive Talk presentation, "Artificial Intelligence and non-/micro-invasive was cost-effective in a Randomized Trial", will be presented by Falk Schwendicke, Charite - Universitaetsmedizin Berlin, Germany and take place on Saturday, June 25th, 2022 at 2 p.m. China Standard Time (UTC+08:00) during the "e-Oral Health Network I" session.

26 Jun 2022

Machine learning can be a successful tool to predict oral cancer risk

The Interactive Talk presentation, "Predicting Oral Cancer Risk using Machine Learning", will take place on Saturday, June 25th, 2022 at 2 p.m. China Standard Time (UTC+08:00) during the "e-Oral Health Network I" session.

26 Jun 2022

Researchers identify orally efficacious antiviral drug against respiratory syncytial virus

An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease, according to researchers in the Center for Translational Antiviral Research at Georgia State University.

24 Jun 2022

Mapping the trajectory of SARS-CoV-2 evolution inside the host

In a recent study posted to the bioRxiv* pre-print server, researchers in the United States mapped the trajectory of within-host evolution of acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

24 Jun 2022

Researchers model a complex childhood disease on-a-chip

Millions of children in low- and middle-income nations suffer from environmental enteric dysfunction (EED), a chronic inflammatory disease of the intestine that is the second leading cause of death in children under five years old.

23 Jun 2022

American College of Radiology issues risk mitigation strategies to address contrast media shortage

GE Healthcare was forced to shut a production plant in April because of a COVID-19 outbreak in Shanghai, China.

23 Jun 2022

Study examines the impact of neoliberalism on oral health of Australian indigenous peoples

A study examining the detrimental effect of neoliberalism on the oral health of Australian indigenous peoples will be presented by Brianna Poirer of the University of Adelaide, Australia during the “Keynote Address; Global Oral Health Inequalities Research Network I” session on Thursday, June 23rd, 2022 at 3:45 p.m. China Standard Time (UTC+08:00) at the 100th General Session and Exhibition of the IADR, to be held in conjunction with the 5th Meeting of the IADR Asia Pacific Region.

23 Jun 2022

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

Researchers evaluated the impact of the OPV on the incidence of COVID-19.

23 Jun 2022

Oral News and Research

New discovery could lead to more effective treatments for asthma sufferers

Researchers investigate prevention and therapy against monkeypox infection

Study highlights the non-inferiority of frozen sperm for intrauterine insemination treatments

SARS-CoV-2 can evade Paxlovid by multiple mechanisms

Antibiotic-resistant strains of typhoid bacteria continue to spread out of South Asia

What you need to know about monkeypox

Drug-resistant typhoid needs to be treated as a global problem

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

Researchers examine the role of perineural invasion in oral cancer outcomes

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Does fecal viral excretion provide insights into on GI symptoms of COVID-19?

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

Study examines the cost-effectiveness of AI-supported detection of proximal caries

Machine learning can be a successful tool to predict oral cancer risk

Researchers identify orally efficacious antiviral drug against respiratory syncytial virus

Mapping the trajectory of SARS-CoV-2 evolution inside the host

Researchers model a complex childhood disease on-a-chip

American College of Radiology issues risk mitigation strategies to address contrast media shortage

Study examines the impact of neoliberalism on oral health of Australian indigenous peoples

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News